Cargando…
Tissue eosinophils express the IL‐33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis
Autores principales: | Uchida, Amiko M, Lenehan, Patrick J, Vimalathas, Praveen, Miller, Kaia C, Valencia‐Yang, Mabel, Qiang, Li, Canha, Lauren A, Ali, Lestat R, Dougan, Michael, Garber, John J, Dougan, Stephanie K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052372/ https://www.ncbi.nlm.nih.gov/pubmed/34614218 http://dx.doi.org/10.1111/all.15127 |
Ejemplares similares
-
Human differentiated eosinophils release IL-13 in response to IL-33 stimulation
por: Uchida, Amiko M., et al.
Publicado: (2022) -
Models and Tools for Investigating Eosinophilic Esophagitis at the Bench
por: Uchida, Amiko M., et al.
Publicado: (2022) -
Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study
por: Garber, John J., et al.
Publicado: (2022) -
Prior hospital‐based infection and risk of eosinophilic esophagitis in a Swedish nationwide case‐control study
por: Uchida, Amiko M., et al.
Publicado: (2022) -
Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
por: Walsh, Michael J, et al.
Publicado: (2023)